Stifel Nicolaus Has Lowered Expectations for Astrana Health (NASDAQ:ASTH) Stock Price

Astrana Health (NASDAQ:ASTH) had its target price reduced by equities researchers at Stifel Nicolaus from $70.00 to $56.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 56.95% from the stock’s previous close.

Other analysts have also issued research reports about the company. Truist Financial dropped their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Robert W. Baird raised their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Finally, Macquarie upgraded shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $63.00.

Astrana Health Trading Down 4.6 %

NASDAQ ASTH opened at $35.68 on Thursday. The stock has a market cap of $2.01 billion, a P/E ratio of 27.45, a price-to-earnings-growth ratio of 1.51 and a beta of 1.20. Astrana Health has a fifty-two week low of $29.08 and a fifty-two week high of $63.20. The stock has a 50 day simple moving average of $35.06 and a two-hundred day simple moving average of $44.99. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC purchased a new stake in Astrana Health in the third quarter worth about $35,000. Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Astrana Health in the 4th quarter worth approximately $40,000. Quarry LP grew its stake in shares of Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company’s stock worth $57,000 after buying an additional 471 shares during the last quarter. KBC Group NV bought a new position in Astrana Health during the 3rd quarter valued at approximately $70,000. Finally, Quest Partners LLC purchased a new position in Astrana Health during the third quarter valued at $133,000. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.